Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhavi D Senagolage

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood Neoplasia|August 12, 2025
NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with <i>TP53</i> inactivationMadhavi D Senagolage, Hunter Z Blaylock, Saira Khan, et al.
Plos Biology|October 8, 2019
Dynamic enhancers control skeletal muscle identity and reprogrammingKrithika Ramachandran, Madhavi D Senagolage, Meredith A Sommars, et al.
Scientific Reports|January 8, 2022
Genomic studies controvert the existence of the CUX1 p75 isoformManisha Krishnan, Madhavi D Senagolage, Jeremy T Baeten, et al.
Elife|April 16, 2019
Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosisMeredith A Sommars, Krithika Ramachandran, Madhavi D Senagolage, et al.
Cell|March 1, 2016
A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating InflammationAnn-Jay Tong, Xin Liu, Brandon J Thomas, et al.
Cell Reports|December 20, 2018
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of ObesityMadhavi D Senagolage, Meredith A Sommars, Krithika Ramachandran, et al.
Nature Metabolism|February 10, 2024
Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasisKrithika Ramachandran, Christopher R Futtner, Meredith A Sommars, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood Neoplasia|August 12, 2025
NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with <i>TP53</i> inactivationMadhavi D Senagolage, Hunter Z Blaylock, Saira Khan, et al.
Plos Biology|October 8, 2019
Dynamic enhancers control skeletal muscle identity and reprogrammingKrithika Ramachandran, Madhavi D Senagolage, Meredith A Sommars, et al.
Scientific Reports|January 8, 2022
Genomic studies controvert the existence of the CUX1 p75 isoformManisha Krishnan, Madhavi D Senagolage, Jeremy T Baeten, et al.
Elife|April 16, 2019
Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosisMeredith A Sommars, Krithika Ramachandran, Madhavi D Senagolage, et al.
Cell|March 1, 2016
A Stringent Systems Approach Uncovers Gene-Specific Mechanisms Regulating InflammationAnn-Jay Tong, Xin Liu, Brandon J Thomas, et al.
Cell Reports|December 20, 2018
Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of ObesityMadhavi D Senagolage, Meredith A Sommars, Krithika Ramachandran, et al.
Nature Metabolism|February 10, 2024
Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasisKrithika Ramachandran, Christopher R Futtner, Meredith A Sommars, et al.
Pageof 1